Trials / Completed
CompletedNCT04866667
Observational Study of ASCVD Risks of Type 2 Diabetes in East China
Screening and Intervention of Arteriosclerotic Cardiovascular Disease in Type 2 Diabetes in Zhejiang Province
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 316 (actual)
- Sponsor
- Zhejiang Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to screen patients with type 2 diabetes with high risk of cardiovascular disease, and intervene with or without Glucagon like peptide-1 receptor agonists.
Conditions
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2023-12-31
- Completion
- 2024-05-31
- First posted
- 2021-04-30
- Last updated
- 2026-04-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04866667. Inclusion in this directory is not an endorsement.